Mark Hancock, an officer and director of PACS Group, Inc., filed a Form 144 notice of proposed sale on October 28, 2026, covering 9,024 shares of common stock to be sold through Citigroup Global Markets Inc. on the New York Stock Exchange.

Key Highlights

  • Proposed sale: 9,024 shares of PACS Group, Inc. common stock with an aggregate market value of $452,120.45, according to the filing.
  • Seller: Mark Hancock, listed as both an officer and a director of the issuer.
  • Broker: Citigroup Global Markets Inc., 388 Greenwich Street, New York, NY 10013, named as the executing broker.
  • Original acquisition: The shares were acquired on March 1, 2023, at the formation of the issuer, from the issuer itself, for cash, with 54,626,199 units acquired at that time.
  • 10b5-1 plan: The filing notes a Rule 10b5-1 plan adoption date of March 3, 2026.
  • Prior sales in past 3 months: Hancock sold 144,318 shares on September 14, 2026, for gross proceeds of $6,432,859.40, and 155,682 shares on September 15, 2026, for gross proceeds of $6,612,032.49.
  • Shares outstanding: 158,026,588 shares of common stock were reported outstanding at the time of filing.

PACS Group Officer and Director Mark Hancock Files Proposed Sale Notice

According to the Form 144 filed with the U.S. Securities and Exchange Commission on October 28, 2026, Mark Hancock, who holds the roles of both officer and director at PACS Group, Inc. (NYSE:PACS), has notified the SEC of a proposed sale of 9,024 shares of the company's common stock. The filing lists an aggregate market value of $452,120.45 for the proposed transaction, to be executed through Citigroup Global Markets Inc. on the NYSE, with an approximate sale date of October 28, 2026.

The filing discloses that the shares proposed for sale were originally acquired on March 1, 2023, described as "shares acquired at formation of the issuer," obtained from the issuer itself for cash consideration. The total amount acquired in that original transaction was reported as 54,626,199 shares. The company's total shares outstanding are listed as 158,026,588.

As required by Form 144, the filing also discloses Hancock's sales of PACS Group common stock during the prior three months. On September 14, 2026, Hancock sold 144,318 shares for gross proceeds of $6,432,859.40, and on September 15, 2026, he sold 155,682 shares for gross proceeds of $6,612,032.49, according to the filing. The filing further indicates that the proposed sale is being made pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2026. Hancock signed the notice as Mark Darrell Hancock.

What Was Disclosed

PACS Group, Inc. officer and director Mark Hancock filed a Form 144 on October 28, 2026, disclosing a proposed sale of 9,024 common shares valued at $452,120.45, to be executed via Citigroup Global Markets Inc. under a 10b5-1 plan adopted March 3, 2026.